The goal of this clinical trial is to investigate the efficacy of an online group prevention program developed for women at risk for eating disorders with randomized controlled trial. The main questions it aims to answer are: * Does the ACT intervention lead to a significant difference in disordered eating behaviors among individuals at risk for eating disorders? * Does the ACT intervention lead to a significant difference in body dissatisfaction among individuals at risk for eating disorders? * Does the ACT intervention lead to a significant difference in obsessive-compulsive and borderline personality beliefs among individuals at risk for eating disorders? * Does body image flexibility significantly affect the impact of the ACT intervention on disordered eating behaviors? * Do self-as-context, cognitive defusion, and present-moment awareness significantly affect the impact of the ACT intervention on disordered eating behaviors? Participant will: Join the online 4-session ACT-based group program Fill the measures at pre-test, post-test and follow-up assessment.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Disordered eating, assesed by the Turkish form of the Eating disorder examination questionnaire (EDE-Q)
Timeframe: Baseline (pretest), week 4(posttest), 3-month follow-up